Non-classic adrenal hyperplasia due to the deficiency of 21-hydroxylase and its relation to polycystic ovarian syndrome

Frontiers of Hormone Research

Volumn 40, Issue , 2013, Pages 158-170

  Pignatelli, Duarte ^a,b  

^a HOSPITAL DE SÃO JOÃO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; FOLLITROPIN; GLUCOCORTICOID; HYDROXYPROGESTERONE; LUTEINIZING HORMONE; PROGESTERONE; STEROID 21 MONOOXYGENASE; TESTOSTERONE; TETRACOSACTIDE; CORTICOTROPIN; CYP21A2 PROTEIN, HUMAN;

AGING; AMENORRHEA AND OLIGOMENORRHEA; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; CARDIOVASCULAR RISK; CONGENITAL ADRENAL HYPERPLASIA; CORTICOTROPIN TEST; FEMALE; FEMALE INFERTILITY; FEMALE SUBFERTILITY; GENE CONVERSION; GENE MUTATION; GENETIC TRANSCRIPTION; GONADOTROPIN RELEASE; HETEROZYGOTE; HIRSUTISM; HUMAN; HYPERANDROGENISM; INSULIN RESISTANCE; MALE TYPE ALOPECIA; OBESITY; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PRECOCIOUS PUBERTY; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRILIZATION; ADRENAL HYPERPLASIA, CONGENITAL; BLOOD; CARDIOVASCULAR DISEASES; COMPLICATION; DIAGNOSTIC USE; DIFFERENTIAL DIAGNOSIS; GENETICS; INFERTILITY, FEMALE; OLIGOMENORRHEA; POLYCYSTIC OVARY SYNDROME; RISK FACTOR;

17-ALPHA-HYDROXYPROGESTERONE; ADRENAL HYPERPLASIA, CONGENITAL; ADRENOCORTICOTROPIC HORMONE; CARDIOVASCULAR DISEASES; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLUCOCORTICOIDS; HETEROZYGOTE; HIRSUTISM; HUMANS; INFERTILITY, FEMALE; INSULIN RESISTANCE; OBESITY; OLIGOMENORRHEA; POLYCYSTIC OVARY SYNDROME; RISK FACTORS; STEROID 21-HYDROXYLASE;

EID: 84870265960     PISSN: 03013073     EISSN: 16623762     Source Type: Book Series    
DOI: 10.1159/000342179     Document Type: Article

References (53)

1. Azziz R, Sanchez LA, Knochenhauer ES, Moran C, Lazenby J, Stephens KC, Taylor K, Boots LR: Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 2004;89:453.
2. Azziz R, Dewailly D, Owerbach D: NCAH: current concepts. J Clin Endocrinol Metab 1994;78:810.
3. Speiser PW: Congenital adrenal hyperplasia owing to 21 hydroxylase deficiency. Endocrinol Metab North Am 2001;30:31.
4. Speiser PW, Knochenhauer ES, Dewailly D, Fruzzetti F, Marcondes JAM, Azziz R: A multicenter study of women with nonclassical congenital adrenal hyperplasia: relationship between genotype and phenotype. Mol Genet Metab 2000;71:527.
5. Kahsar-Miller MD, Nixon C, Boots LR, Go RC, Azziz R: Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. Fertil Steril 2001;75:53-58.
6. Legro R, Driscoll D, Strauss J, Fox J, Dunaif A: Evidence for a genetic basis for hyper-adrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci USA 1998;95:14956-14960.
7. Urbanek M, Legro RS, Driscoll DA, Azziz R, Ehrmann DA, Norman RJ, Strauss JF 3rd, Spielman RS, Dunaif A: Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Proc Natl Acad Sci USA 1999;96:8573-8578.
8. Yildiz BO, Yarali H, Oguz H, Bayraktar M: Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003;88:2031-2036.
9. Ewens K, Stewart DR, Ankener W, Urbanek M, McAllister J, Chen C, Baig K, Parker S, Margulies EH, Legro RS, Dunaif A, Strauss JF 3rd, Spielman R: Family-based analysis of candidate genes for polycystic ovary syndrome. J Clin Endocrinol Metab 2010;95:2306-2315.
10. Armengaud JB, Charkaluk ML, Trivin C, Tardy V, Bréart G, Brauner R, Chalumeau M: Precocious pubarche: distinguishing late-onset congenital adrenal hyperplasia from premature adrenarche. J Clin Endocrinol Metab 2009;94:2835-2840.
11. Carmina E, Rosato F, Janni A, Rizzo M, Longo R: Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab 2006;91:2-6.
12. Witchel SF, Azziz R: Congenital adrenal hyperplasia. J Pediatr Adolesc Gynecol 2011;24:116-126.
13. Robyr D, Llor J, Gaudin G, Schneider N: PCOS and CAH a different entity for comparable phenotypes? Rev Med Suisse 2007;3:116;1595-1596.
14. Pall M, Azziz R, Beires J, Pignatelli D: The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia. Fertil Steril 2010;94: 684.
15. Moran C, Azziz R: 21-Hydroxylase deficient nonclassic adrenal hyperplasia: the great pretender. Semin Reprod Med 2003;21:295-300.
16. Kumar A, Woods KS, Bartolucci AA, Azziz R: Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf) 2005;62:644-649.
17. Moran C, Reyna R, Boots L, Azziz R: Adrenocortical hyperresponsiveness to ACTH in PCOS patients with adrenal androgen excess. Fertil Steril 2004; 81:126-131.
18. Miller D, Emans SJ, Kohane I: Follow-up study of adolescent girls with a history of premature pubarche. J Adolesc Health 1996;18:301-305.
19. Ibanez L, Potau N, Zampolli M, Street ME, Carrascosa A: Girls diagnosed with premature pubarche show an exaggerated ovarian androgen synthesis from the early stages of puberty: evidence from gonadotropin-releasing hormone agonist testing. Fertil Steril 1997;67:849-855.
20. Meas T, Chevenne D, Thibaud E, Leger J, Cabrol S, Czernichow P, Levy-Marchal C: Endocrine consequences of premature pubarche in post-pubertal Caucasian girls. Clin Endocrinol (Oxf) 2002;57:101-106.
21. McKenna T, Cunningham S: Adrenal abnormalities in PCOS and the impact of their correction; in Dunaif A, Givens J, Haseltine F, Merriam G (eds): Polycystic Ovary Syndrome. Oxford, Blackwell Scientific Publications, 1992, pp 183-193.
22. Moran C, Azziz R, Carmina E, Dewailly D, Fruzzetti F, Ibanez L, Knochenhauer ES, Marcondes JA, Mendonca BB, Pignatelli D, Pugeat M, Rohmer V, Speiser PW, Witchel SF: 21-Hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study. Am J Obstet Gynecol 2000;183:1468-1474.
23. Invitti C, Pecori Giraldi F, Dubini A, De Martin M, Cavagnini F: Increased urinary free cortisol and decreased serum corticosteroid-binding globulin in polycystic ovary syndrome. Acta Endocrinol (Copenh) 1991;125:28-32.
24. Vogeser M, Halser B, Baron A, Jacob K, Demant T: Corticosteroid-binding globulin and unbound serum cortisol in women with PCOS. Clin Biochem 2000;33:157-159.
25. Stewart PM, Penn R, Holder R, Parton A, Ratcliffe JG, London DR: The hypothalamo-pituitary-adrenal axis across the normal menstrual cycle and in polycystic ovary syndrome. Clin Endocrinol (Oxf) 1993;38:387-391.
26. Stewart PM, Shackleton CH, Beastall GH, Edwards CR: 5 alpha-reductase activity in polycystic ovary syndrome. Lancet 1990;335:431-433.
27. Chin D, Shackleton C, Prasad VK, Kohn B, David R, Imperato-McGinley J, Cohen H, McMahon DJ, Oberfield SE: Increased 5á-reductase and normal 11β-hydroxysteroid dehydrogenase metabolism of C19 and C21 steroids in a young population with polycystic ovarian syndrome. J Pediatr Endocrinol Metab 2000;13:253-259.
28. Fassnacht M, Schlenz N, Schneider SB, Wudy SA, Allolio B, Arlt W: Beyond adrenal and ovarian androgen generation: increased peripheral 5 alphareductase activity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003;88:2760-2766.
29. Rodin A, Thakkar H, Taylor N, Clayton R: Hyperandrogenism in PCOS. Evidence of dysregulation of 11 beta-hydroxysteroid dehydrogenase. N Engl J Med 1994;330:460-465.
30. Speiser PW, White PC: Congenital adrenal hyperplasia. N Engl J Med 2003;349:776-788.
31. White P, Speiser P: Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000;21:245-291.
32. Speiser P, Azziz R, Baskin L, Ghizzoni L, Hensle T, Merke D, Meyer-Bahlburg H, Miller W, Montori V, Oberfield S, Ritzen M, White P: Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2010;95:4133-4160.
33. Glintborg D, Hermann AP, Brusgaard K, Hangaard J, Hagen C, Andersen M: Significantly higher adrenocorticotropin-stimulated cortisol and 17-hydroxyprogesterone levels in 337 consecutive, preme nopausal, Caucasian, hirsute patients compared with healthy controls. J Clin Endocrinol Metab 2005;90:1347-1353.
34. Witchel SF, Lee PA: Identification of heterozygotic carriers of 21-hydroxylase deficiency: sensitivity of ACTH stimulation tests. Am J Med Genet 1998; 76:337-342.
35. Escobar Morreale H, San Millan J, Smith R, Sanch J, Witchel S: The presence of the 21-hydroxylase deficiency carrier status in hirsute women: phenotype-genotype correlations. Fertil Steril 1999;72: 629-638.
36. Dacou-Voutetakis C, Dracopoulou M: High incidence of molecular defects of the CYP21A2 gene in patients with premature adrenarche. J Clin Endocrinol Metab 1999;84:1570-1574.
37. Witchel SF, Kahsar-Miller M, Aston CE, White C, Azziz R: Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess. Fertil Steril 2005;83:371-375.
38. Kim MS, Merke DP: Cardiovascular disease risk in adult women with CAH due to 21-hydroxylase deficiency Semin Reprod Med 2008;27:316-321.
39. Wild RA, Rizzo M, Clifton S, Carmina E: Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril 2011;95:1073-1079.
40. Arlt W, Willis DS, Wild SH, Krone N, Doherty EJ, Hahner S, Han TS, Carroll PV, Conway GS, Rees DA, Stimson RH, Walker BR, Connell JM, Ross RJ: United Kingdom Congenital Adrenal Hyperplasia Adult Study Executive (CaHASE). Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients. J Clin Endocrinol Metab 2010;95:5110-5121.
41. Fauser B, Bouchard P: Uncertainty remains in women with PCOS regarding the increased incidence of cardiovascular disease later in life, despite the indisputable presence of multiple cardiovascular risk factors at a young age. J Clin Endocrinol Metab 2011;96:1-3.
42. Volkl TM, Simm D, Korner A, Rascher W, Kiess W, Kratzsch J, Dorr HG: Does an altered leptin axis play a role in obesity among children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency? Eur J Endocrinol 2009;160:239-247.
43. Saygili F, Oge A, Yilmaz C: Hyperinsulinemia and insulin insensitivity in women with NCAH due to 21-hydroxylase deficiency: the relationship between serum leptin levels and chronic hyperinsulinemia. Horm Res 2005;63:270-274.
44. Kroese JM, Mooij CF, van der Graaf M, Hermus AR, Tack CJ: Pioglitazone improves insulin resistance and decreases blood pressure in adult patients with congenital adrenal hyperplasia. Eur J Endocrinol 2009;161:887-894.
45. Speiser PW, Serrat J, New MI, et al: Insulin insensitivity in adrenal hyperplasia due to nonclassical steroid 21-hydroxylase deficiency. J Clin Endocrinol Metab 1992;75:1421-1424.
46. Sam S, Dunaif A: PCOS: syndrome XX? Trends Endocrinol Metab 2003;14:365-370.
47. Arslanian SA, Lewy V, Danadian K, Saad R: Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance. J Clin Endocrinol Metab 2002;87:1555-1559.
48. Kelly S, McKenna T, Young L: Modulation of steroidogenic enzymes by orphan nuclear transcriptional regulation may control diverse production of cortisol and androgens in the human adrenal. J Endocrinol 2004;181:355-365.
49. Feldman S, Billaud L, Thalabard JC, Raux-Demay MC, Mowszowicz I, Kuttenn F, Mauvais-Jarvis P: Fertility in women with late-onset adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 1992;74:635-639.
50. Moran C, Azziz R, Weintrob N, Witchel S, Rohmer V, Dewailly D, Marcondes J, Pugeat M, Speiser P, Pignatelli D, Mendonca B, Bachega T, Escobar-Morreale H, Carmina E, Fruzzetti F, Kelestimur F: Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia. J Clin Endocrinol Metab 2006;91:3451-3456.
51. Koivunen R, Pouta A, Franks S, Martikainen H, Sovio U, Hartikainen AL, McCarthy MI, Ruokonen A, Bloigu A, Järvelin MR, Morin-Papunen L: Fecundability and spontaneous abortions in women with self-reported oligo-amenorrhea and/or hirsutism: Northern Finland Birth Cohort 1966 Study. Hum Reprod 2008;23:2134-2139.
52. Bidet M, Bellanné-Chantelot C, Galand-Portier MB, Golmard JL, Tardy V, Morel Y, Clauin S, Coussieu C, Boudou P, Mowzowicz I, Bachelot A, Touraine P, Kuttenn F: Fertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 2010;95: 1182-1190.
53. Orio F, Vuolo L, Palomba S, Lombardi G, Colao A: Metabolic and cardiovascular consequences of polycystic ovary syndrome. Minerva Ginecol 2008;60: 39-51.